Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,075 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

A Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM (Multiple Myeloma).

NCT00838357

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Front Line Mobilization, +20 more
Locations
  • Hôpital du Haut Lévêque Bordeaux, France
  • Hôpital Lyon Sud Lyon, France
  • Institut Paoli Calmettes Marseille, France
  • CHU Hotel-Dieu Université de Nantes Nantes, France
View all 26 locations
View Trial Details
Completed

An Investigational Drug, Palbociclib (PD-0332991), Is Being Studied In Combination With Velcade And Dexamethasone In Patients With Multiple Myeloma. Patients Must Have Received Prior Treatment For Multiple Myeloma.

NCT00555906

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Northwestern Medical Faculty Foundation Chicago, Illinois, United States
  • Northwestern Memorial Hospital/Main Labs Chicago, Illinois, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • University of Kansas Cancer Center and Medical Pavilion Westwood, Kansas, United States
View all 19 locations
View Trial Details

Related conditions